Altitude and Diving Physiology — MCQs

Q: Ascent to high altitude may cause all of the following except:

Cerebral palsy. **Explanation:** The physiological changes at high altitude are primarily driven by **hypobaric hypoxia** (low partial pressure of oxygen). **Why Cerebral Palsy is the correct answer:** Cerebral palsy is a non-progressive clinical syndrome resulting from an insult to the **developing fetal or infant brain** (typically due to birth asphyxia, infection, or trauma). It is a developmental neurological disorder and is not an acute or chronic manifestation of high-altitude exposure in adults or children. **Analysis of incorrect options:** * **Cerebral Edema (HACE):** High Altitude Cerebral Edema occurs due to hypoxia-induced cerebral vasodilation and increased capillary permeability (vasogenic edema). It is a life-threatening emergency. * **Pulmonary Edema (HAPE):** Hypoxia causes **hypoxic pulmonary vasoconstriction (HPV)**. When this is uneven or severe, it leads to increased pulmonary capillary hydrostatic pressure and leakage of fluid into the alveoli. * **Venous Thrombosis:** High altitude increases the risk of thromboembolism due to a "Virchow’s triad" effect: **Hemoconcentration** (increased hematocrit due to erythropoietin release), dehydration, and relative stasis during cold-induced inactivity. **High-Yield Clinical Pearls for NEET-PG:** * **HAPE** is the most common cause of death related to high altitude. * **Acetazolamide** (a carbonic anhydrase inhibitor) is the drug of choice for prophylaxis of Acute Mountain Sickness (AMS) as it induces metabolic acidosis, stimulating ventilation. * **Nifedipine** is used for the prevention/treatment of HAPE by reducing pulmonary artery pressure. * **Dexamethasone** is the drug of choice for HACE.

Q: Monge's disease refers to:

High Altitude Erythrocytosis. **Explanation:** **Monge’s Disease**, also known as **Chronic Mountain Sickness (CMS)**, is a condition that develops in long-term residents of high altitudes (usually above 3,000 meters). **Why the correct answer is right:** The hallmark of Monge’s disease is **High Altitude Erythrocytosis**. Due to chronic exposure to low partial pressure of oxygen ($FiO_2$), the body overproduces erythropoietin, leading to an excessive increase in red blood cell mass (hematocrit often >65%). This results in extreme blood hyperviscosity, leading to symptoms like cyanosis, fatigue, headache, and right-sided heart failure (cor pulmonale). **Why the incorrect options are wrong:** * **Primary Familial Polycythemia:** This is a genetic condition caused by mutations in the erythropoietin receptor; it is not triggered by altitude. * **Spurious Polycythemia (Gaisbock’s Syndrome):** This occurs when plasma volume decreases (e.g., dehydration or stress), making the RBC count appear high relatively, though the total RBC mass remains normal. * **Polycythemia Vera:** This is a myeloproliferative neoplasm (primary polycythemia) caused by a mutation in the **JAK2 gene**, leading to autonomous RBC production regardless of oxygen levels. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** The definitive treatment for Monge’s disease is **descent to lower altitudes**. Periodic phlebotomy can provide symptomatic relief. * **Acetazolamide:** Often used for Acute Mountain Sickness (AMS), it works by inducing metabolic acidosis, which stimulates ventilation. * **Key Distinction:** Unlike Acute Mountain Sickness or HAPE, Monge’s disease is a **chronic** maladaptation to altitude.

Q: Which of the following is seen in high altitude climbers?

Decreased PaCO2. **Explanation:** The primary physiological challenge at high altitude is the decrease in barometric pressure, which leads to a lower partial pressure of inspired oxygen ($PiO_2$). This results in **hypoxia**. **Why B is the correct answer:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. While hyperventilation (Option A) is a physiological *process* that occurs, the question asks what is *seen* (the biochemical result) in the climber. Increased ventilation causes excessive "washing out" of Carbon Dioxide from the lungs. This leads to **Hypocapnia** (Decreased $PaCO_2$) and subsequent respiratory alkalosis. This decrease in $PaCO_2$ is a hallmark finding in acute altitude exposure. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While this occurs, it is the *mechanism* rather than the resultant laboratory/blood gas finding. In many competitive exams, if both a process and its direct chemical result are listed, the specific biochemical change ($PaCO_2$) is often the preferred answer. * **C. Pulmonary Edema:** High Altitude Pulmonary Edema (HAPE) is a pathological complication, not a universal finding in all climbers. It occurs due to uneven hypoxic pulmonary vasoconstriction. * **D. Hypertension:** Systemic hypertension is not a standard finding; however, **Pulmonary Hypertension** occurs due to hypoxic pulmonary vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve:** Initially shifts to the **right** (due to increased 2,3-BPG) to favor oxygen unloading at tissues. * **Polycythemia:** Chronic exposure stimulates Erythropoietin (EPO) release from the kidneys, increasing RBC count. * **Acetazolamide:** The drug of choice for Acute Mountain Sickness (AMS); it inhibits carbonic anhydrase, causing bicarbonate diuresis and metabolic acidosis, which counteracts the respiratory alkalosis and stimulates breathing.

A 25-year-old elite swimmer training at sea level travels to compete at altitude (2400 meters). After 2 days of acclimatization, she experiences decreased performance. Her arterial blood gas shows pH 7.46, PaO2 65 mmHg, PaCO2 32 mmHg, HCO3- 22 mEq/L. Analyze the limiting factor for her current exercise performance at altitude.

Q2Easy

Ascent to high altitude may cause all of the following except:

Q3Easy

Monge's disease refers to:

Q4Medium

Which of the following is seen in high altitude climbers?

Q5Medium

Acclimatization to high altitude is associated with which of the following changes?

Altitude and Diving Physiology Indian Medical PG Practice Questions and MCQs

Question 1: A 25-year-old elite swimmer training at sea level travels to compete at altitude (2400 meters). After 2 days of acclimatization, she experiences decreased performance. Her arterial blood gas shows pH 7.46, PaO2 65 mmHg, PaCO2 32 mmHg, HCO3- 22 mEq/L. Analyze the limiting factor for her current exercise performance at altitude.

A. Decreased plasma volume reducing stroke volume and cardiac output
B. Alkalosis shifting the oxygen-hemoglobin dissociation curve leftward
C. Incomplete respiratory compensation reducing oxygen delivery
D. Inadequate time for erythropoietin-stimulated red blood cell production (Correct Answer)
E. Reduced oxidative enzyme activity in skeletal muscle mitochondria

Explanation: ***Inadequate time for erythropoietin-stimulated red blood cell production*** - While **erythropoietin (EPO)** levels rise within hours of arrival at altitude, significant **polycythemia** and increased red cell mass take **2-4 weeks** to develop. - After only 2 days, the athlete has a lower **PaO2** without the increased **hemoglobin (Hb)** needed to restore total **arterial oxygen content (CaO2)**, limiting her aerobic capacity. *Decreased plasma volume reducing stroke volume and cardiac output* - **Plasma volume** does decrease shortly after reaching altitude, which can lower **stroke volume**, but this is typically a secondary factor compared to the oxygen-carrying deficit. - At 2400m, the primary limitation at submaximal exercise is the **hypoxia** rather than a failure of the **frank-starling mechanism**. *Alkalosis shifting the oxygen-hemoglobin dissociation curve leftward* - The **respiratory alkalosis** (pH 7.46) causes a **left shift**, which increases oxygen affinity in the lungs but may hinder **unloading** at tissues. - This effect is often self-limiting as levels of **2,3-BPG** rise within days to shift the curve back to the right, mitigating this as a primary performance limiter. *Incomplete respiratory compensation reducing oxygen delivery* - The ABG shows a **PaCO2 of 32 mmHg**, indicating that **hypoxic ventilatory response** and respiratory compensation are already active and functioning well. - The primary issue is not the lack of breathing effort but the low **ambient PIO2** and the time-lag for the body to produce more **oxygen carriers**. *Reduced oxidative enzyme activity in skeletal muscle mitochondria* - Changes in **oxidative enzyme activity** and mitochondrial density are slow-onset **peripheral adaptations** that occur over much longer periods of altitude training. - This factor reflects a chronic adaptation rather than an acute limiting factor for performance after only **48 hours** of exposure.

Question 2: Ascent to high altitude may cause all of the following except:

A. Cerebral edema
B. Pulmonary edema
C. Cerebral palsy (Correct Answer)
D. Venous thrombosis

Explanation: **Explanation:** The physiological changes at high altitude are primarily driven by **hypobaric hypoxia** (low partial pressure of oxygen). **Why Cerebral Palsy is the correct answer:** Cerebral palsy is a non-progressive clinical syndrome resulting from an insult to the **developing fetal or infant brain** (typically due to birth asphyxia, infection, or trauma). It is a developmental neurological disorder and is not an acute or chronic manifestation of high-altitude exposure in adults or children. **Analysis of incorrect options:** * **Cerebral Edema (HACE):** High Altitude Cerebral Edema occurs due to hypoxia-induced cerebral vasodilation and increased capillary permeability (vasogenic edema). It is a life-threatening emergency. * **Pulmonary Edema (HAPE):** Hypoxia causes **hypoxic pulmonary vasoconstriction (HPV)**. When this is uneven or severe, it leads to increased pulmonary capillary hydrostatic pressure and leakage of fluid into the alveoli. * **Venous Thrombosis:** High altitude increases the risk of thromboembolism due to a "Virchow’s triad" effect: **Hemoconcentration** (increased hematocrit due to erythropoietin release), dehydration, and relative stasis during cold-induced inactivity. **High-Yield Clinical Pearls for NEET-PG:** * **HAPE** is the most common cause of death related to high altitude. * **Acetazolamide** (a carbonic anhydrase inhibitor) is the drug of choice for prophylaxis of Acute Mountain Sickness (AMS) as it induces metabolic acidosis, stimulating ventilation. * **Nifedipine** is used for the prevention/treatment of HAPE by reducing pulmonary artery pressure. * **Dexamethasone** is the drug of choice for HACE.

Question 3: Monge's disease refers to:

A. Primary Familial Polycythemia
B. High Altitude Erythrocytosis (Correct Answer)
C. Spurious Polycythemia
D. Polycythemia Vera

Explanation: **Explanation:** **Monge’s Disease**, also known as **Chronic Mountain Sickness (CMS)**, is a condition that develops in long-term residents of high altitudes (usually above 3,000 meters). **Why the correct answer is right:** The hallmark of Monge’s disease is **High Altitude Erythrocytosis**. Due to chronic exposure to low partial pressure of oxygen ($FiO_2$), the body overproduces erythropoietin, leading to an excessive increase in red blood cell mass (hematocrit often >65%). This results in extreme blood hyperviscosity, leading to symptoms like cyanosis, fatigue, headache, and right-sided heart failure (cor pulmonale). **Why the incorrect options are wrong:** * **Primary Familial Polycythemia:** This is a genetic condition caused by mutations in the erythropoietin receptor; it is not triggered by altitude. * **Spurious Polycythemia (Gaisbock’s Syndrome):** This occurs when plasma volume decreases (e.g., dehydration or stress), making the RBC count appear high relatively, though the total RBC mass remains normal. * **Polycythemia Vera:** This is a myeloproliferative neoplasm (primary polycythemia) caused by a mutation in the **JAK2 gene**, leading to autonomous RBC production regardless of oxygen levels. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** The definitive treatment for Monge’s disease is **descent to lower altitudes**. Periodic phlebotomy can provide symptomatic relief. * **Acetazolamide:** Often used for Acute Mountain Sickness (AMS), it works by inducing metabolic acidosis, which stimulates ventilation. * **Key Distinction:** Unlike Acute Mountain Sickness or HAPE, Monge’s disease is a **chronic** maladaptation to altitude.

Question 4: Which of the following is seen in high altitude climbers?

A. Hyperventilation
B. Decreased PaCO2 (Correct Answer)
C. Pulmonary edema
D. Hypertension

Explanation: **Explanation:** The primary physiological challenge at high altitude is the decrease in barometric pressure, which leads to a lower partial pressure of inspired oxygen ($PiO_2$). This results in **hypoxia**. **Why B is the correct answer:** In response to hypoxia, peripheral chemoreceptors (carotid and aortic bodies) are stimulated, leading to **hyperventilation**. While hyperventilation (Option A) is a physiological *process* that occurs, the question asks what is *seen* (the biochemical result) in the climber. Increased ventilation causes excessive "washing out" of Carbon Dioxide from the lungs. This leads to **Hypocapnia** (Decreased $PaCO_2$) and subsequent respiratory alkalosis. This decrease in $PaCO_2$ is a hallmark finding in acute altitude exposure. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While this occurs, it is the *mechanism* rather than the resultant laboratory/blood gas finding. In many competitive exams, if both a process and its direct chemical result are listed, the specific biochemical change ($PaCO_2$) is often the preferred answer. * **C. Pulmonary Edema:** High Altitude Pulmonary Edema (HAPE) is a pathological complication, not a universal finding in all climbers. It occurs due to uneven hypoxic pulmonary vasoconstriction. * **D. Hypertension:** Systemic hypertension is not a standard finding; however, **Pulmonary Hypertension** occurs due to hypoxic pulmonary vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** * **Oxygen Dissociation Curve:** Initially shifts to the **right** (due to increased 2,3-BPG) to favor oxygen unloading at tissues. * **Polycythemia:** Chronic exposure stimulates Erythropoietin (EPO) release from the kidneys, increasing RBC count. * **Acetazolamide:** The drug of choice for Acute Mountain Sickness (AMS); it inhibits carbonic anhydrase, causing bicarbonate diuresis and metabolic acidosis, which counteracts the respiratory alkalosis and stimulates breathing.

Question 5: Acclimatization to high altitude is associated with which of the following changes?

A. Hyperventilation
B. Polycythemia
C. Oxygen dissociation curve shifts to the right (Correct Answer)
D. Decreased concentration of systemic capillaries

Explanation: ### Explanation Acclimatization to high altitude involves several physiological adjustments to compensate for the decrease in the partial pressure of inspired oxygen ($PiO_2$). **Why Option C is Correct:** At high altitudes, low oxygen levels stimulate the production of **2,3-Bisphosphoglycerate (2,3-BPG)** within red blood cells. An increase in 2,3-BPG decreases the affinity of hemoglobin for oxygen, causing the **Oxygen Dissociation Curve (ODC) to shift to the right**. This shift is beneficial because it facilitates the **unloading of oxygen** from hemoglobin into the peripheral tissues, ensuring better oxygenation despite the hypoxic environment. **Analysis of Incorrect Options:** * **A. Hyperventilation:** While hyperventilation occurs immediately upon exposure to altitude (via peripheral chemoreceptors), it is an **acute response** rather than a long-term feature of established acclimatization. Over time, the body adjusts to the resulting respiratory alkalosis. * **B. Polycythemia:** This is a classic feature of acclimatization (increased RBC count due to Erythropoietin). However, in the context of this specific question, the **rightward shift of the ODC** is often considered the hallmark metabolic adaptation for tissue delivery. *Note: In many exams, both B and C are correct; however, if forced to choose the most immediate metabolic adaptation for tissue delivery, the ODC shift is prioritized.* * **D. Decreased concentration of systemic capillaries:** This is incorrect. Acclimatization actually leads to **increased capillarity** (angiogenesis) in tissues to decrease the diffusion distance for oxygen. **High-Yield NEET-PG Pearls:** 1. **ODC Shifts:** "CADET, face Right!" (Increase in **C**O2, **A**cid/H+, **D**PG, **E**xercise, and **T**emperature shifts the curve to the right). 2. **Pulmonary Circulation:** Unlike systemic vessels, pulmonary vessels undergo **hypoxic pulmonary vasoconstriction**, which can lead to High-Altitude Pulmonary Edema (HAPE). 3. **Acid-Base:** Acclimatization results in a "compensated respiratory alkalosis" as the kidneys excrete bicarbonate to offset the CO2 lost through hyperventilation.

Practice by Chapter

Atmospheric Pressure and Gas Laws

Practice Questions

High Altitude Acclimatization

Practice Questions

Hypoxia and Oxygen Transport

Practice Questions

Altitude Illnesses

Practice Questions

Hyperbaric Environments

Practice Questions

Decompression Theory

Practice Questions

Physiology of Breath-Hold Diving

Practice Questions

Nitrogen Narcosis

Practice Questions

Oxygen Toxicity

Practice Questions

Fitness for Altitude and Diving

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free